Peking University First Hospital: Delirium trials

The registry lists 12 Delirium studies with Peking University First Hospital as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 4 6No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU PatientsNot yet recruitingNCT06468436Not applicable
• Impact of Remimazolam on Prognosis After Bladder Cancer SurgeryRecruitingNCT04532606Phase 4
• Dexmedetomidine and Delirium in Patients After Cardiac SurgeryCompletedNCT02267538Phase 4Results posted
• Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU PatientsCompletedNCT07151716Phase 4
• Low-Dose Dexmedetomidine for Delirium Prevention in Mechanically Ventilated Septic PatientsTerminatedNCT04876937Not applicable
• Dexmedetomidine and 5-year Outcome in Elderly Patients After SurgeryCompletedNCT03436472Not applicable
• Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer SurgeryTerminatedNCT03200600Phase 4
• Low-dose Dexmedetomidine in Mechanically Ventilated ICU PatientsSuspendedNCT03172897Phase 4
• Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative DeliriumCompletedNCT03012984Not applicable
• Dexmedetomidine and Long-term Outcome in Elderly Patients After SurgeryCompletedNCT02809937Phase 4
• Impact of Anesthesia Maintenance Methods on Incidence of Postoperative DeliriumCompletedNCT02662257Not applicable
• Anesthesia-analgesia Methods and Postoperative DeliriumCompletedNCT01661907Not applicable